Gary L. Keeney

14.3k total citations
197 papers, 9.5k citations indexed

About

Gary L. Keeney is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology. According to data from OpenAlex, Gary L. Keeney has authored 197 papers receiving a total of 9.5k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Reproductive Medicine, 83 papers in Obstetrics and Gynecology and 43 papers in Oncology. Recurrent topics in Gary L. Keeney's work include Endometrial and Cervical Cancer Treatments (78 papers), Ovarian cancer diagnosis and treatment (75 papers) and Uterine Myomas and Treatments (27 papers). Gary L. Keeney is often cited by papers focused on Endometrial and Cervical Cancer Treatments (78 papers), Ovarian cancer diagnosis and treatment (75 papers) and Uterine Myomas and Treatments (27 papers). Gary L. Keeney collaborates with scholars based in United States, Italy and Canada. Gary L. Keeney's co-authors include Karl C. Podratz, Andrea Mariani, Maurice J. Webb, William A. Cliby, Sean C. Dowdy, Lynn C. Hartmann, Michael G. Haddock, Jamie N. Bakkum‐Gamez, Amy L. Weaver and Ann L. Oberg and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Gary L. Keeney

195 papers receiving 9.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary L. Keeney United States 56 4.1k 4.0k 2.1k 1.7k 1.7k 197 9.5k
Elvio G. Silva United States 54 4.1k 1.0× 2.8k 0.7× 1.9k 0.9× 1.9k 1.1× 1.3k 0.8× 157 8.2k
Michael T. Deavers United States 65 4.9k 1.2× 2.7k 0.7× 3.3k 1.6× 1.8k 1.1× 3.2k 1.9× 226 11.5k
Russell Vang United States 52 4.1k 1.0× 2.1k 0.5× 1.9k 0.9× 1.7k 1.0× 1.5k 0.9× 169 7.9k
Colin J.R. Stewart Australia 39 2.7k 0.7× 1.8k 0.4× 1.9k 0.9× 1.5k 0.9× 1.7k 1.0× 208 6.7k
Marisa R. Nucci United States 55 2.7k 0.7× 3.8k 0.9× 1.1k 0.6× 1.6k 0.9× 1.2k 0.8× 196 7.8k
Esther Oliva United States 67 5.1k 1.3× 5.8k 1.4× 1.9k 0.9× 2.7k 1.6× 3.2k 1.9× 296 12.9k
Brigitte M. Ronnett United States 57 4.2k 1.0× 2.8k 0.7× 1.4k 0.7× 2.9k 1.7× 1.3k 0.8× 155 8.9k
Michelle S. Hirsch United States 45 2.4k 0.6× 1.3k 0.3× 1.7k 0.8× 1.6k 0.9× 2.5k 1.5× 194 7.5k
Richard J. Zaino United States 56 5.4k 1.3× 7.7k 1.9× 1.8k 0.9× 2.6k 1.5× 1.0k 0.6× 153 11.7k
Michael G. Muto United States 40 4.7k 1.1× 2.4k 0.6× 1.2k 0.6× 974 0.6× 1.5k 0.9× 123 7.0k

Countries citing papers authored by Gary L. Keeney

Since Specialization
Citations

This map shows the geographic impact of Gary L. Keeney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary L. Keeney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary L. Keeney more than expected).

Fields of papers citing papers by Gary L. Keeney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary L. Keeney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary L. Keeney. The network helps show where Gary L. Keeney may publish in the future.

Co-authorship network of co-authors of Gary L. Keeney

This figure shows the co-authorship network connecting the top 25 collaborators of Gary L. Keeney. A scholar is included among the top collaborators of Gary L. Keeney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary L. Keeney. Gary L. Keeney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Sukov, William R., Jain Zhou, Katherine B. Geiersbach, et al.. (2023). Frequency of HER2 protein overexpression and HER2 gene amplification in endometrial clear cell carcinoma. Human Pathology. 137. 94–101. 5 indexed citations
4.
Gill, Sarah, Simone Garzon, Francesco Multinu, et al.. (2021). Ultrastaging of ‘negative’ pelvic lymph nodes in patients with low- and intermediate-risk endometrioid endometrial cancer who developed non-vaginal recurrences. International Journal of Gynecological Cancer. 31(12). ijgc–2021. 3 indexed citations
5.
Murphy, Brittany L., Judy C. Boughey, Michael Keeney, et al.. (2018). Factors Associated With Positive Margins in Women Undergoing Breast Conservation Surgery. Mayo Clinic Proceedings. 93(4). 429–435. 21 indexed citations
6.
Carroll, Katherine, et al.. (2018). Seeing what works: identifying and enhancing successful interprofessional collaboration between pathology and surgery. Journal of Interprofessional Care. 35(4). 490–502. 13 indexed citations
7.
Wang, Chen, Sebastian M. Armasu, Kimberly R. Kalli, et al.. (2017). Pooled Clustering of High-Grade Serous Ovarian Cancer Gene Expression Leads to Novel Consensus Subtypes Associated with Survival and Surgical Outcomes. Clinical Cancer Research. 23(15). 4077–4085. 65 indexed citations
8.
Hendrickson, Andrea E. Wahner, Kieran Hawthorne, Ellen L. Goode, et al.. (2015). Assessment of published models and prognostic variables in epithelial ovarian cancer at Mayo Clinic. Gynecologic Oncology. 137(1). 77–85. 16 indexed citations
9.
Galanis, Evanthia, Lynn C. Hartmann, William A. Cliby, et al.. (2010). Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer. Cancer Research. 70(3). 875–882. 252 indexed citations
10.
Bakkum‐Gamez, Jamie N., Debra L. Richardson, Leigh G. Seamon, et al.. (2010). Is There a High-Risk Subgroup of Stage I Epithelial Ovarian Cancer That Is Most Likely to Benefit From 6 Versus 3 Cycles of Adjuvant Chemotherapy?. International Journal of Gynecological Cancer. 20(7). 1125–1131. 5 indexed citations
11.
Mariani, Andrea, Thomas J. Sebo, Jerry A. Katzmann, et al.. (2005). HER-2/neu overexpression and hormone dependency in endometrial cancer: analysis of cohort and review of literature.. PubMed. 25(4). 2921–7. 20 indexed citations
12.
Dowdy, Sean C., Andrea Mariani, Monica M. Reinholz, et al.. (2004). Overexpression of the TGF-β antagonist Smad7 in endometrial cancer. Gynecologic Oncology. 96(2). 368–373. 46 indexed citations
13.
Dowdy, Sean C., Dennis J. O’Kane, Gary L. Keeney, Jeff Boyd, & Karl C. Podratz. (2001). Telomerase Activity in Sex Cord–Stromal Tumors of the Ovary. Gynecologic Oncology. 82(2). 257–260. 5 indexed citations
14.
Roche, Patrick C., et al.. (2000). Molecular and Cytokinetic Pretreatment Risk Assessment in Endometrial Carcinoma. Gynecologic Oncology. 77(1). 1–7. 24 indexed citations
15.
Murphy, David, Allan J. Pantuck, Kiron M. Das, et al.. (1999). FEMALE URETHRAL ADENOCARCINOMA: IMMUNOHISTOCHEMICAL EVIDENCE OF MORE THAN 1 TISSUE OF ORIGIN. The Journal of Urology. 161(6). 1881–1884. 45 indexed citations
16.
Cliby, William A., Gary L. Keeney, Vera J. Suman, et al.. (1997). Expression of nm23/Nucleoside Diphosphate Kinase-A Protein in Endometrial Carcinoma. Gynecologic Oncology. 66(2). 238–245. 4 indexed citations
17.
Lacy, Martha Q., Lynn C. Hartmann, Gary L. Keeney, et al.. (1995). c-erbB-2 and p53 expression in fallopian tube carcinoma. Cancer. 75(12). 2891–2896. 28 indexed citations
18.
Persons, Diane L., Lynn C. Hartmann, John F. Herath, et al.. (1993). Interphase molecular cytogenetic analysis of epithelial ovarian carcinomas.. PubMed. 142(3). 733–41. 40 indexed citations
19.
Hetzel, David J., Timothy O. Wilson, Gary L. Keeney, et al.. (1992). HER-2/neu expression: A major prognostic factor in endometrial cancer. Gynecologic Oncology. 47(2). 179–185. 175 indexed citations
20.
Ransom, David, Shreyaskumar Patel, Gary L. Keeney, George D. Malkasian, & John H. Edmonson. (1990). Papillary serous carcinoma of the peritoneum. A review of 33 cases treated with platin-based chemotherapy. Cancer. 66(6). 1091–1094. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elvio G. Silva Breakdown of academic impact, for papers by Michael T. Deavers Breakdown of academic impact, for papers by Russell Vang Breakdown of academic impact, for papers by Colin J.R. Stewart Breakdown of academic impact, for papers by Marisa R. Nucci Breakdown of academic impact, for papers by Esther Oliva Breakdown of academic impact, for papers by Brigitte M. Ronnett Breakdown of academic impact, for papers by Michelle S. Hirsch Breakdown of academic impact, for papers by Richard J. Zaino Breakdown of academic impact, for papers by Michael G. Muto
Rankless by CCL
2026